Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the Literature

Tong, Hoi Y.; Díaz, Carmen; Collantes, Elena; Medrano, Nicolás; Borobia, Alberto M.; Jara, Paloma; Ramírez, Elena
January 2015
Case Reports in Pediatrics;1/22/2015, Vol. 2015, p1
Academic Journal
Case Study
Background. Methylphenidate (MPH) is widely used in treating children with attention-deficit-hyperactivity disorder. Hepatotoxicity is a rare phenomenon; only few cases are described with no liver failure. Case. We report on the case of a 12-year-old boy who received MPH for attention-deficit-hyperactivity disorder. Two months later the patient presented with signs and symptoms of hepatitis and MPH was discontinued, showing progressive worsening and developing liver failure and a liver transplantation was required. Other causes of liver failure were ruled out and the liver biopsy was suggestive of drug toxicity. Discussion. One rare adverse reaction of MPH is hepatotoxicity. The review of the literature shows few cases of liver injury attributed to MPH; all of them recovered after withdrawing the treatment. The probable mechanism of liver injury was MPH direct toxicity to hepatocytes. In order to establish the diagnosis of MPH-induced liver injury, we used CIOMS/RUCAM scale that led to an assessment of “possible” relationship. This report provides the first published case of acute MPH-induced liver failure with successful hepatic transplantation. Conclusions. It is important to know that hepatotoxicity can occur in patients with MPH treatment and monitoring the liver’s function is highly recommended.


Related Articles

  • USE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A BRIDGE TO TRANSPLANTATION IN FULMINANT HEPATIC FAILURE DUE TO BUDD-CHIARI SYNDROME. Shrestha, Roshan; Durham, Janette D.; Wachs, Michael; Bilir, Bahri M.; Kam, Igal; Trouillot, Thomas; Everson, Gregory T. // American Journal of Gastroenterology;Dec1997, Vol. 92 Issue 12, p2304 

    We report a case of fulminant hepatic failure in a 55-yr-old man due to Budd-Chiari syndrome in the setting of polycythemia rubra vera. The patient presented with acute hepatic failure, which rapidly progressed to grade IV hepatic encephalopathy. Placement of a transjugular intrahepatic...

  • Fulminant Hepatic Failure. Fingerote, Robert J.; Bain, Vincent G. // American Journal of Gastroenterology;Jul1993, Vol. 88 Issue 7, p1000 

    Fulminant hepatic failure (FHF) is defined as acute liver failure with hepatic encephalopathy in patients with no history or stigmata of chronic liver disease. Historically, its prognosis was extremely poor. However, the emergence of orthotopic liver transplantation as a viable form of therapy...

  • Phenelzine: Acute toxic cytolytic hepatitis: case report.  // Reactions Weekly;6/22/2019, Vol. 1758 Issue 1, p279 

    No abstract available.

  • A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. Rössle, Martin; Ochs, Andreas; Gülberg, Veit; Siegerstetter, Volker; Holl, Joseph; Deibert, Peter; Olschewski, Manfred; Reiser, Maximilian; Gerbes, Alexander L. // New England Journal of Medicine;06/08/2000, Vol. 342 Issue 23, p1701 

    Background: In patients with cirrhosis and ascites, creation of a transjugular intrahepatic portosystemic shunt may reduce the ascites and improve renal function. However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain. Methods: We randomly assigned...

  • Fulminant hepatic failure in woman with iron and non-steroidal anti-inflammatory drug intoxication. Magdalan, Jan; Zawadzki, Marcin; Sozański, Tomasz // Human & Experimental Toxicology;Aug2011, Vol. 30 Issue 8, p1106 

    A 17-year-old, previously healthy female ingested 16,000 mg iron sulphate (96.15 mg of iron ions per kg of b.wt.) with a suicidal intent. The patient was admitted to a toxicology unit 10 hours after the drug ingestion. Serum iron concentration at admission was 2351 μg% (421.0 μmol/L). In...

  • Acute liver failure caused by severe acute hepatitis B: a case series from a multi-center investigation. Chun-ya Wang; Pan Zhao; Wei-wei Liu // Annals of Clinical Microbiology & Antimicrobials;2014, Vol. 13 Issue 1, p1 

    Background Few data can be available regarding acute liver failure (ALF) caused by severe acute hepatitis B up to now. This study aims to report such cases from China. Findings We conducted a multi-center investigation on ALF from 7 tertiary hospitals in different areas of China. A total of 11...

  • Survival of patient with late onset hepatic failure by living-related liver transplantation from maternal donor with incompatible blood type. Kojima, Akira; Takagi, Hitoshi; Abe, Takehiko; Sakurai, Seiji; Sohara, Naondo; Kakizaki, Satoru; Nagamine, Takeaki; Mori, Masatomo; Matsunami, Masatoshi; Ikegami, Toshihiko; Hashikura, Yasuhiko; Kawasaki, Seiji; Makuuchi, Masatoshi; Kojima, A; Takagi, H; Abe, T; Sakurai, S; Sohara, N; Kakizaki, S; Nagamine, T // Journal of Gastroenterology;1998, Vol. 33 Issue 6, p899 

    A 14-year-old girl with blood type B with late onset hepatic failure (LOHF) of unknown cause has survived through living-related liver transplantation (LRLT). No hepatitis virus, including HAV, HBV, HCV, and HGV, was positive at the onset of LOHF. Autoimmune hepatitis was thought to be the cause...

  • Artificial Liver Support -- Pipe Dream or Reality? Cattral, Mark S.; Levy, Gary A. // New England Journal of Medicine;7/28/94, Vol. 331 Issue 4, p268 

    The article presents information on fulminant hepatic failure including its treatments, and characteristics. Fulminant hepatic failure is characterized by the rapid appearance of jaundice, coagulopathy, and encephalopathy and reflects severe hepatocellular injury or necrosis. It is stated that...

  • Prognostic Indicators for Acute Liver Failure Development and Mortality in Patients with Hepatitis A: Consecutive Case Analysis. Hye Sun Shin; Sae Pyul Kim; Sang Hoon Han; Do Young Kim; Sang Hoon Ann; Kwang-Hyub Han; Chae Yoon Chon; Jun Yong Park // Yonsei Medical Journal;Jun2014, Vol. 55 Issue 4, p953 

    Purpose: Due to the seroepidemiological shift in hepatitis A (HA), its severity, mortality, and complications have increased in recent years. Thus, the aim of this study was to identify predictive factors associated with poor prognosis among patients with HA. Materials and Methods: A total of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics